High CREPT expression occurs in approximately 47 to 78% of tumors compared to normal tissues, which has been confirmed in various cancers through immunohistochemistry and Western blot analysis in samples obtained from various cancer patients [11,17,27,28]. This evidence concerns the gene RPRD1B and cancer.